LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Uprichard, J; Peng, Y (2017)
Publisher: SAGE Publications (UK and US)
Languages: English
Types: Article
Subjects:

Classified by OpenAIRE into

mesheuropmc: hemic and lymphatic diseases
Anaemia is a condition in which the number of red cells necessary to meet the body's physiological requirements is insufficient. Iron deficiency anaemia (IDA) and the anaemia of chronic disease (ACD) are the two most common causes of anaemia worldwide; iron homeostasis plays a pivotal role in the pathogenesis of both diseases. An understanding of how iron studies can be used to distinguish between these diseases is therefore essential, not only for diagnosis but also in guiding management. This review will primarily focus on IDA and ACD; however iron overload in anaemia will also be briefly discussed.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011-23
    • 2. Ganz T. Systemic Iron Homeostasis. Physiol Rev 2013; 93:1721-41
    • 3. Illing AC, Shawki A, Cunningham CL, Mackenzie B. Substrate profile and metal -ion selectivity of human divalent metal-ion transporter-1. J BiolChem 2012; 287:30485-96
    • 4. McKie AT, Marciani P, Rolfs A, et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5:299-309
    • 5. Gulec S, Anderson GJ, Collins JF. Mechanistic and regulatory aspects of intestinal iron absorption. Am J Physiol Gastrointest Liver Physiol 2014; 307:G397-409
    • 6. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homeostasis. J Clin Pathol 2011; 64:281-6
    • 7. Merle U, Theilig F, Fein E, et al. Localization of the iron-regulatory proteins hemojuvelin and transferrin receptor 2to the basolateral membrane domain of hepatocytes. Histochem Cell Biol 2007; 127:221-6
    • 8. Waldvogel-Abramowskia S, Waeber G, Gassner C, et al. Physiology of Iron Metabolism. Transfus Med Hemother 2014; 41:213-21
    • 9. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-3
    • 10. Cohen LA, Gutierrez L, Weiss A, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 2010; 116:1574-84
    • 11. Gibson R. Principles of nutritional assessment. 2nd ed. Oxford: Oxford University Press; 2005
    • 12. Loría A, Hershko C, Konijn AM. Serum Ferritin in an Elderly Population. J Gerontol 1979; 34:521-524
    • 13. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1) (http://www.who.int/vmnis/indicators/haemoglobin. pdf, accessed [27th May 2016])
    • 14. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-54
    • 15. Takami T, Sakaida I. Iron regulation by hepatocytes and free radicals. J Clin Biochem Nutr 2011; 48:103-6
    • 16. Dale JC, Burritt MF, Zinsmeister AR. Diurnal Variation of Serum Iron, Iron-Binding Capacity, Transferrin Saturation, and Ferritin Levels. Am J Clin Pathol 2002; 117:802-9
    • 17. Ramsay WN. The measurement of serum transferrin by iron-binding capacity. J Clin Pathol 1973; 26:691-6
    • 18. World Health Organization, Centers for Disease Control and Prevention. Assessing the iron status of populations. 2nd ed. 2007. ISBN: 978 92 4 1596107 (electronic version) (http://apps.who.int/iris/bitstream/10665/75368/1/9789241596107_eng.pdf?ua=1, accessed [27th May 2016])
    • 19. van Bokhoven MA, van Deursen CT, Swinkels DW. Diagnosis and management of hereditary haemochromatosis. BMJ 2011; 342:c7251
    • 20. Bain, B. Blood Cells: A Practical Guide. 4th edn. Blackwell Oxford; 2006
    • 21. Ganz T, Nemeth E. Hepcidin and Iron Homeostasis. Biochim Biophys Acta 2012; 1823:1434- 43
    • 22. Guyatt GH, Oxman AD, Ali M, Willan A, McIlroy W, Patterson C. Laboratory diagnosis of iron deficiency anaemia: an overview. J Gen Intern Med 1992; 7:145-53
    • 23. Goddard AF, James MW, McIntyre AS, Scott BB. Guidelines for the Management of Iron Deficiency Anaemia. Gut 2011; 60:1309-16
    • 24. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med 1993; 44:63-74.
    • 25. Feelders R. Structure, function and clinical significance of transferrin receptors. Clin Chem Lab Med 1999; 37:1-10
    • 26. Baillie FJ, Morrison AE, Fergus I. Soluble transferrin receptor: a discriminating assay for iron deficiency. Clin Lab Haematol 2003; 25:353-7
    • 27. WHO. Serum transferrin receptor levels for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2014 (WHO/NMH/NHD/MNM/14.6; http://apps.who.int/iris/bitstream/10665/133707/1/WHO_NMH_NHD_EPG_14.6_eng.pdf?u a=1, accessed [27th May 2016])
    • 28. Infusino I, Braga F, Dolci A, Panteghini M. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin Pathol 2012; 138:642-9
    • 29. Cartwright GE, Wintrobe MM. Anemia of infection. Adv Intern Med 1962; 5:165-226
    • 30. Fitzsimons EJ. The anaemia of chronic disease. BMJ 2001; 322:811-2
    • 31. Eschbach JW. Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness. J Am Soc Nephrol 2002; 13:1412-4
    • 32. de Francisco AL, Stenvinkel P, Vaulont S. Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness. NDT Plus 2009; 2(Suppl_1): i18-i26
    • 33. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101:2461- 63
    • 34. Gangat N, Wolanskyj AP. Erratum: “Anemia of Chronic Disease”. Semin Hematol 2013; 50:232-238
    • 35. Zarychanski R, Houston DS. Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response? CMAJ 2008; 179:333-7
    • 36. O'Shea MJ, Kershenobich D, Tavil lAS. Effects of Inflammation on Iron and Transferrin Metabolism. Br J Haematol 1973; 25:707-14
    • 37. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R. Zinc protoporphyrin in anemia of chronic disorders. Blood 1993; 81:1200-4
    • 38. Cullis JO. Diagnosis and management of anaemia of chronic disease : current status.Br J Haematol 2011; 154:289-300
    • 39. Goodnough LT. The new age of iron: evaluation and management of iron-restricted erythropoiesis. Sem Hematol 2009; 46:325-7
    • 40. Walter PB, Fung EB, Killilea DW, et al. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br J Haematol 2006; 135:254-63
    • 41. Nielsen P, Günther U, Dürken M, Fischer R, Düllmann J. Serum ferritin iron in iron overload and liver damage: correlation to body iron stores and diagnostic relevance. J Lab Clin Med 2000; 135:413-8
    • 42. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105:855-61
    • 43. Cazzola M, Della Porta MG, Malcovati L. Clinical Relevance of Anemia and Transfusion Iron Overload in Myelodysplastic Syndromes. Hematology Am Soc Hematol Educ Program 2008; 2008:166-75
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article